Vincidol-MR contains Diclofenac 50 mg + PCM 325 mg + Chlorzoxazone 250 mg which is offered by Solway Pharmaceuticals. The multiple pathways involved in body’s perception of pain, a combination therapy is well suited for pain management. Diclofenac acts by attenuation of peripheral prostaglandin synthesis and marked anti-inflammatory properties. Paracetamol acts centrally and inhibits brain prostaglandin synthesis which may partly account for its well documented actively to reduce fever and induce analgesia. Chlorzoxazone being a centrally acting muscle relaxant relieves muscular spasms. The combination exerts a better pain control due to action on different pathways of pain.